Source: Annual Congress 2010 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Montani, F. Coulet, B. Girerd, M. Eyries, H. Mal, R. Borie, C. Dromer, C. Marquette, G. Zalcman, C. O‘Connell, D. O‘Callaghan, L. Savale, X. Jaïs, O. Sitbon, G. Simonneau, M. Humbert, F. Soubrier (Clamart, Paris, France). Pulmonary hypertension in patients with neurofibromatosis type I. Eur Respir J 2010; 36: Suppl. 54, 3525

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension associated with neurofibromatosis type 1 Source: Eur Respir Rev, 27 (149) 180053; 10.1183/16000617.0053-2018 Year: 2018 Pulmonary hypertension associated with neurofibromatosis type 1: data from the French Pulmonary Hypertension Registry Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019 Pulmonary microangiopathy as a possible complication in patients with diabetes mellitus Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004 Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Clinical features of pulmonary tuberculosis in patients with diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012 Radiological features of pulmonary tuberculosis in patients with diabetes mellitus Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 Pulmonary tuberculosis and diabetes mellitus Source: Eur Respir J 2006; 28: Suppl. 50, 506s Year: 2006 The coexisting pulmonary tuberculosis and diabetes mellitus Source: Eur Respir J 2006; 28: Suppl. 50, 26s Year: 2006 Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2? Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis Source: Eur Respir Rev 2009; 18: 125-128 Year: 2009 The association of pulmonary fibrosis with diabetes mellitus Source: ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020 Year: 2020 Diabetes mellitus: a risk factor for idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis Year: 2007 Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Prevalence of pulmonary hypertension in a large cohort of patients with hereditary hemorrhagic telangiectasia Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it. Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004 Pulmonary tuberculosis and diabetes mellitus in Belgrade Source: Eur Respir J 2002; 20: Suppl. 38, 364s Year: 2002 Pulmonary hypertension associated with sarcoidosis Source: Eur Respir Mon 2012; 57: 166-181 Year: 2012 Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis Source: Eur Respir J 2002; 20: 59-65 Year: 2002 Incidence and outcomes of haemoptysis in patients with operable and non-operable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016